Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.
Genenta Science has raised $15.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Genenta Science's investors include Mediobanca, Club degli Investitori, Growth Engine, ENEA Tech e Biomedical, iStarter.
Genenta Science is headquartered in Milano, Italy.
Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.
Genenta Science is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genenta Science — Funding & Investors." VCBacked, October 26, 2025, https://www.vcbacked.co/company/genenta-science. Accessed August 14, 2026.
VCBacked. (2025). Genenta Science — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/genenta-science
{{cite web |title=Genenta Science — Funding & Investors |url=https://www.vcbacked.co/company/genenta-science |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated